Plenary Panel: How is Real World Data used to provide additional evidence for conditional regulatory approvals and initial reimbursement decisions?

Plenary Panel: How is Real World Data used to provide additional evidence for conditional regulatory approvals and initial reimbursement decisions?

Wednesday, November 4, 2020 8:10 AM to 9:20 AM · 1 hr. 10 min. (Africa/Abidjan)
Plenary Keynote

Information

- European initiatives exploring the potential for RWD to generate real-world evidence (RWE) that can inform key healthcare decisions about treatment efficacy, value and optimization of patient care

- What new initiatives are emerging in 2020 and how could they aid assessment of rare disease treatments

- The potential for better collaboration and joint learnings

- Followed by an open discussion with audience, ensuring to engage patient group leaders


Log in